SummaryBackgroundMetabolic syndrome (MS) associated with systemic inflammation identifies high-risk cardiovascular diseases (CVDs). Deteriorated renal function leads to poor cardiovascular outcomes. However, the relationship between such metabolic anomaly, systemic inflammation and renal function in patients diagnosed with peripheral arterial disease (PAD) remains largely unknown.Materials and methodsA total of 249 consecutive individuals meeting the study criteria from our outpatient clinics were enrolled in the study. Baseline demographic data and information regarding metabolic abnormalities [presented as Adult Treatment Panel (ATP) III scores], high-sensitivity C-reactive protein (Hs-CRP) level, and estimated renal function [calculated ...
OBJECTIVE The knowledge on the level of systemic inflammation in peripheral artery disease (PAD) ...
Background—Although renal insufficiency is a recognized risk factor for coronary artery disease, lit...
Objective To determine whether the increase in plasma levels of C-Reactive Protein (CRP), a non-spec...
Background: Metabolic syndrome (MS) associated with systemic inflammation identifies high-risk cardi...
ObjectiveMetabolic syndrome is defined by the clustering in the same person of at least three risk f...
Peripheral Arterial Disease (PAD) is a common disease experienced by more than 202 million people wo...
Peripheral arterial disease (PAD) includes a wide range of manifestations in the tower timb, from as...
AbstractBackgroundChronic kidney disease (CKD) is an evolving paradigm for the risk assessment of ca...
Aims: High ankle-brachial index (ABI) is marker of increased cardiovascular morbidity and mortality,...
Prior studies evaluating metabolic syndrome (MetS) and incident peripheral artery disease (PAD) have...
Item does not contain fulltextBACKGROUND: Some evidence suggests that chronic kidney disease is a ri...
BACKGROUND AND AIMS: Metabolic syndrome (MetS) was reported to be associated with increased cardiova...
Background: While chronic renal damage is a condition with low-grade inflammation, the potential r...
Background—The metabolic syndrome (MetS) is associated with incident myocardial infarction and strok...
BACKGROUND: Some evidence suggests that chronic kidney disease is a risk factor for lower-extremity ...
OBJECTIVE The knowledge on the level of systemic inflammation in peripheral artery disease (PAD) ...
Background—Although renal insufficiency is a recognized risk factor for coronary artery disease, lit...
Objective To determine whether the increase in plasma levels of C-Reactive Protein (CRP), a non-spec...
Background: Metabolic syndrome (MS) associated with systemic inflammation identifies high-risk cardi...
ObjectiveMetabolic syndrome is defined by the clustering in the same person of at least three risk f...
Peripheral Arterial Disease (PAD) is a common disease experienced by more than 202 million people wo...
Peripheral arterial disease (PAD) includes a wide range of manifestations in the tower timb, from as...
AbstractBackgroundChronic kidney disease (CKD) is an evolving paradigm for the risk assessment of ca...
Aims: High ankle-brachial index (ABI) is marker of increased cardiovascular morbidity and mortality,...
Prior studies evaluating metabolic syndrome (MetS) and incident peripheral artery disease (PAD) have...
Item does not contain fulltextBACKGROUND: Some evidence suggests that chronic kidney disease is a ri...
BACKGROUND AND AIMS: Metabolic syndrome (MetS) was reported to be associated with increased cardiova...
Background: While chronic renal damage is a condition with low-grade inflammation, the potential r...
Background—The metabolic syndrome (MetS) is associated with incident myocardial infarction and strok...
BACKGROUND: Some evidence suggests that chronic kidney disease is a risk factor for lower-extremity ...
OBJECTIVE The knowledge on the level of systemic inflammation in peripheral artery disease (PAD) ...
Background—Although renal insufficiency is a recognized risk factor for coronary artery disease, lit...
Objective To determine whether the increase in plasma levels of C-Reactive Protein (CRP), a non-spec...